AST Comments on OPTN Policy Proposals

Tuesday, July 9, 2013

The AST recently commented on the following OPTN policy proposals:

  • Proposal to Redefine the Role of the Vice-President of the Board of Directors
  • Propoal to Add Serum Sodium to the MELD Score
  • Proposed Changed to the OPTN Bylaws Governing Histocompatibility Labs
  • Proposed Update to the HLA Equivalency Tables in Appendix 3A
  • Proposal to Clarify Requirements for Independent Donor Advocates (IDA) at Living Kidney Donor Recovery Center
  • Proposal to Change Pediatric Heart Allocation Policy

Click here to read AST's comments